Gilead is inspired by the work that our grantees do every day to improve access and eliminate barriers to healthcare, and advance education among patients and healthcare professionals. Gilead supports projects across all of our therapeutic areas — HIV, liver diseases, hematology and oncology, and inflammatory and respiratory diseases.

HIV

Continual advances in medical research help millions of people living with HIV have longer, more fulfilling lives today. But HIV continues to have a devastating impact, especially on people who belong to underserved communities and who lack access to medical care. Gilead supports organizations working to help individuals learn their status and get the care they need. We also support organizations that aim to solve the challenges of tomorrow, including how to:

• Understand the impact HIV has on an aging population

• Ensure continuity and retention in care

• Spark appreciation for innovative thinking in HIV treatment

• Identify and create a new generation of advocates

HIV Cure

Gilead works to address the HIV epidemic by discovering transformative and life-saving medicines, developing simplified treatment regimens that increase efficacy, expanding access to treatment for those who need it most, and building communities among people affected by HIV and AIDS. Continuing on this commitment, Gilead will partner with and support institutions, community groups, and organizations that are engaged in HIV cure activities by providing grant funding.

HIV Prevention

More tools than ever are now available to help prevent HIV infection. Yet about 40,000 new cases of HIV are still reported in the U.S. each year. Gilead supports the efforts of community-based organizations, public health entities and similar nonprofit organizations to educate their constituents about comprehensive HIV prevention, including the role of pre-exposure prophylaxis (PrEP). Specifically, Gilead supports programs designed to:

• Provide comprehensive education on the range of prevention options and strategies available

• Ensure biomedical prevention plans, such as PrEP, are implemented safely and effectively in accordance with recommended guidelines

• Engage communities and individuals at highest risk for HIV infection in prevention efforts

Liver Disease

Each year, more Americans die from Hepatitis C than HIV. Yet public awareness of this disease remains limited because of its disproportionate impact on drug users, minorities and other at-risk groups. Gilead is working to change this by funding organizations that raise awareness of the importance of testing and access to care among these groups, as well as those that:

• Look for ways to increase treatment capacity and sustainability

• Move individuals down the care pathway from screening to cure

• Eliminate intrinsic barriers to care and treatment

Oncology

Cancer remains one of the greatest health challenges we face. While the search for a cure continues, education and awareness are powerful tools to support diagnosis and treatment. Gilead supports organizations focused on health equity in order to:

• Enable people affected by cancer and their caregivers to make informed health decisions

• Educate healthcare providers on identification, screening, and diagnosis

• Improve access to prevention and treatment by overcoming barriers to care

Inflammatory and Respiratory Diseases

From cystic fibrosis (CF) to influenza, inflammatory and respiratory diseases have a substantial impact on people of every age, gender, ethnic group, and economic class. Gilead funds organizations that work in this therapeutic area to:

• Improve individuals’ health literacy, enabling them to make informed health decisions

• Educate healthcare providers on identification, screening and diagnosis

• Improve access to treatment by overcoming financial and other obstacles